Addex Therapeutics | 7.75 -0.25 -3.13% | ||
| ADXN | |||
| 高 7.95 | 开 7.95 | 量 8938股 | 总市值 954.80万 |
| 低 7.44 | 换 0.73% | 额 6.80万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
Addex Therapeutics(ADXN)
02-03 19:15
$Addex Therapeutics(ADXN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-26-000580 Act: 34 Size: 18 KB 网页链接
Addex Therapeutics(ADXN)
01-07 19:15
$Addex Therapeutics(ADXN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-26-000110 Act: 34 Size: 16 KB 网页链接
Addex Therapeutics(ADXN)
2025-12-11 05:05
$Addex Therapeutics(ADXN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-25-119967 Act: 33 Size: 1 MB 网页链接
Addex Therapeutics(ADXN)
2025-12-11 05:05
$Addex Therapeutics(ADXN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-25-119971 Act: 34 Size: 78 KB 网页链接
Addex Therapeutics(ADXN)
2025-12-08 19:25
$Addex Therapeutics(ADXN)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003556 Act: 33 Size: 1 KB 网页链接
Addex Therapeutics(ADXN)
2025-12-04 19:05
$Addex Therapeutics(ADXN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-25-118226 Act: 34 Size: 1 MB 网页链接
Addex Therapeutics(ADXN)
2025-11-20 05:06
$Addex Therapeutics(ADXN)$ F-3 Registration statement by foreign private issuers Accession Number: 0001104659-25-114077 Act: 33 Size: 1 MB 网页链接
Addex Therapeutics(ADXN)
2025-10-29 18:45
$Addex Therapeutics(ADXN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-25-006744 Act: 34 Size: 13 KB 网页链接
Addex Therapeutics(ADXN)
2025-09-30 18:15
$Addex Therapeutics(ADXN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-25-094663 Act: 34 Size: 9 MB 网页链接
Addex Therapeutics(ADXN)
2025-09-23 18:15
$Addex Therapeutics(ADXN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-25-006022 Act: 34 Size: 13 KB 网页链接
Addex Therapeutics(ADXN)
2025-06-30 18:15
$Addex Therapeutics(ADXN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-25-004208 Act: 34 Size: 15 KB 网页链接
Addex Therapeutics(ADXN)
2025-06-25 18:15
$Addex Therapeutics(ADXN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-25-004087 Act: 34 Size: 13 KB 网页链接
Addex Therapeutics(ADXN)
2025-06-24 04:05
$Addex Therapeutics(ADXN)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001104659-25-061660 Act: 34 Size: 16 KB 网页链接
Addex Therapeutics(ADXN)
2025-06-20 18:05
$Addex Therapeutics(ADXN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-25-060772 Act: 34 Size: 687 KB 网页链接
Addex Therapeutics(ADXN)
2025-06-06 18:15
$Addex Therapeutics(ADXN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-25-003746 Act: 34 Size: 15 KB 网页链接
Addex Therapeutics(ADXN)
2025-05-16 04:05
$Addex Therapeutics(ADXN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001104659-25-049380 Act: 34 Size: 18 MB 网页链接
Addex Therapeutics(ADXN)
2025-05-12 18:15
$Addex Therapeutics(ADXN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-25-003038 Act: 34 Size: 15 KB 网页链接
Addex Therapeutics(ADXN)
2025-05-01 04:05
$Addex Therapeutics(ADXN)$ NT 20-F Notification of inability to timely file Form 20-F Accession Number: 0001104659-25-042472 Act: 34 Size: 33 KB 网页链接
Addex Therapeutics(ADXN)
2025-04-30 18:25
$Addex Therapeutics(ADXN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-25-002621 Act: 34 Size: 15 KB 网页链接
Addex Therapeutics(ADXN)
2025-04-25 18:25
$Addex Therapeutics(ADXN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-25-002501 Act: 34 Size: 1 MB 网页链接